Global Brain Monitoring Devices Market Size, Share, Forecast Report, 2020-2027

Global Brain Monitoring Devices Market is expected to grow at a CAGR of 6% during the forecast period 2019 to 2025.

Market Synopsis

The ability to quantify reliable alterations in the physical and biochemical environment after a brain injury is of great value in the prevention, medication, and understanding of secondary injuries.

Moreover, according to CDC, traumatic brain injury is a leading cause of mortality, responsible for 2.8 million accidents and emergency department visits annually in the US and about 1 million in the UK. It is one of the most common causes of mortality in people aged under 25, and its incidence is high in adults and infants as well.
Segmentation

By Application

Stroke: High incidence of stroke is expected to support the growth of this segment during the forecast period. For instance, in the US, according to the American Heart Association, about 795,000 individuals suffer from strokes annually. Also, in the Americas, around 4 million stroke patients survived with impairments, and about 15% to 30% are living with a permanent disability. Moreover, according to the American Heart Association, around USD 33 billion is being spent as a direct and indirect cost for stroke in the US. Hence, the stroke segment is holding the largest market share in the global brain monitoring devices market.
Headache Disorders: Headache disorders are among the most common disorders of the nervous system. According to WHO, it has been anticipated that almost half of the adult population has had a headache at least once within the last year. Further, headache has been underestimated, under-recognized and under-treated throughout the world, which is further anticipated to contribute to the market growth.
Epilepsy: According to the World Health Organization (WHO) Report 2017, approximately 50 million people worldwide had epilepsy, making it one of the most common neurological diseases globally. Nearly 80% of the people with epilepsy live in low- and middle-income countries. In many parts of the world, people with epilepsy and their families suffer from stigma and discrimination. According to the new morbidity and mortality weekly report 2017, more people were living with epilepsy in the US than ever before. As a result, the epilepsy segment is expected to be the fastest-growing segment in the brain monitoring device market.
Parkinson’s Disease: Parkinson's disease is a liberal nervous system disorder that affects body movement. Symptoms start gradually, sometimes starting with a barely noticeable tremor in just one hand. Tremors are common, but the disorder also commonly causes stiffness or slowing of movement.
By Type

X Rays: X-rays systems are highly preferred during medical diagnosis as they are comparatively affordable than similar medical procedures such as MRI or CT scans. The rising number of product clearances in recent years is significantly contributing to the growth of this segment. For instance, in February 2019, Koninklijke Philips N.V. received 510(k) clearance from the US Food and Drug Administration (FDA) to market the DigitalDiagnost C90, its newest premium digital radiography system. Thus, this segment is expected to showcase high growth potential over the near future. The X Rays segment is expected to hold the largest market share in the global brain monitoring devices market.
MRI Systems: MRI is a non-invasive medical imaging technique performed in radiology that uses strong magnetic fields and radio waves to produce detailed images of the inside of the body. The MRI segment would register a substantial CAGR during the forecast period owing to its growing adoption by healthcare providers as MRI provides a clearer and more detailed pictures. However, MRI is costlier than X-ray imaging, which is anticipated to affect its adoption during the next six years. MRI systems available in the market are Ingenia Edition 3.0T, Ingenia Ambition 1.5T, and Ingenia MR-RT (Philips Healthcare) and MAGNETOM Sola.
CT: Computed tomography is the imaging process which uses ultra-advanced ray technology to produce a more detailed and cross-sectional image of the human body. As per an article published by CBS News, the number of CT scans performed each year in the US was 3 million in 1980, which increased to 80 million in 2015. Rising adoption of CT scans is expected to boost the market growth over the forecast period
By End-User

Hospital & Clinical: Hospitals and clinics have a large control of the global market for brain monitoring devices. The positive growth of hospitals and clinics segment is attributed to factors such as growing prevalence and incidence of the brain disorders
Research Laboratories and Academic Institutes: Research Laboratories and Academic Institutes take up the second-largest share due to the rising research and development in the market

Key Players

• Advanced Brain Monitoring
• Philips Healthcare
• GE Healthcare
• Siemens Healthineers
• Nihon Kohden Corporation
• Medtronic
• Drägerwerk AG & Co. KGaA
• Neurosoft
• Integra LifeSciences Corporation
• Olympus Corporation